Roche Holding AG - Cost of Goods Sold Including Depreciation and Amortization
Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The item "Cost-of-Goods-Sold-Including-Depreciation-and-Amortization" stands at 12.32 Billion Swiss Francs for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value at least since 12/31/2011, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -21.76 percent compared to the value the year prior.
The 1 year change in percent is -21.76.
The 3 year change in percent is -39.04.
The 5 year change in percent is -42.57.
The 10 year change in percent is -41.50.
The Serie's change in percent from it's minimum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 03/31/2023, to it's latest available value, on 06/30/2025, is -54.63%.
Cost of Goods Sold Including Depreciation and Amortization for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Cost of Goods Sold Including Depreciation and Amortization | 905,699,262,464.00 |
 | Johnson & Johnson - Cost of Goods Sold Including Depreciation and Amortization | 486,508,953,600.00 |
 | AbbVie Inc - Cost of Goods Sold Including Depreciation and Amortization | 399,570,305,024.00 |
 | AstraZeneca PLC - Cost of Goods Sold Including Depreciation and Amortization | 280,205,508,085.11 |
 | Novartis AG - Cost of Goods Sold Including Depreciation and Amortization | 255,096,620,580.91 |